Effects Of Brain-Derived Neurotrophic Factor & C-Reactive Protein On Cognitive Impairment In Schizophrenia: Existing Evidence
Cognitive impairment is a core feature of schizophrenia spectrum disorders, known to affect individuals even before their first episode of psychosis. Affected cognitive domains where impairment is considered a defining and virtually universal characteristic in schizophrenia include attention/vigilance, working memory, executive function, episodic memory, verbal memory, social cognition, and language.1 Other cognitive domains such as semantic memory, fear extinction, processing speed, visual memory, and procedural memory are also affected, though not evidenced at the same severity.1
While environmental and lifestyle factors …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.